Moderna Says Its COVID-19 Shot Works in Kids as Young as 12

Written by LAURAN NEERGAARD

Moderna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the U.S.

With global vaccine supplies still tight, much of the world is struggling to vaccinate adults in the quest to end the pandemic. But earlier this month, the U.S. and Canada authorized another vaccine — the shot made by Pfizer and BioNTech — to be used starting at age 12.

Moderna aims to be next in line, saying it will submit its teen data to the U.S. Food and Drug Administration and other global regulators early next month.

The company studied more than 3,700 12- to 17-year-olds. Preliminary findings showed the vaccine triggered the same signs of immune protection in kids as it does in adults, and the same kind of temporary side effects such as sore arms, headache and fatigue.

There were no COVID-19 diagnoses in those given two doses of the Moderna vaccine compared with four cases among kids given dummy shots. In a press release, the company also said the vaccine appeared 93% effective two weeks after the first dose.

While children are far less likely than adults to get seriously ill from COVID-19, they represent about 14% of the nation’s coronavirus cases. At least 316 have died in the U.S. alone, according to a tally by the American Academy of Pediatrics.

With plenty of vaccine supply in the U.S., younger teens flocked to get Pfizer’s shot in the days after FDA opened it to them, part of a push to get as many kids vaccinated as possible before the next school year.

Both Pfizer and Moderna have begun testing in even younger children, from age 11 down to 6-month-old babies. This testing is more complex: Teens receive the same dose as adults, but researchers are testing smaller doses in younger children. Experts hope to see some results in the fall.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Photo via AP Photo/Hans Pennink.

‹

Shots for Tots: NC Begins COVID-19 Vaccines for Young Children

The Centers for Disease Control recently approved both Moderna and Pfizer vaccines for children as young as six months. Locally, Orange County vaccines for the young age group are available starting Monday and by appointment only at the Southern Human Services Center in Chapel Hill.

Moderna Sues Pfizer Over Patents Behind COVID-19 Vaccine

Written by TOM MURPHY COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine. Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, […]

Duke Expert Details Vaccine Efficacy Amid Emerging COVID-19 Variants

North Carolina opens vaccine eligibility to all groups on Wednesday – a major step in the reopening process for the state. Although vaccinations are increasing, the Centers for Disease Control warns of variants of the virus emerging from places like the United Kingdom, South Africa, and Brazil, spreading through the U.S.

Governor Cooper Visits UNC Health Vaccination Clinic

On Tuesday, Governor Roy Cooper and North Carolina Department of Health and Human Services  Secretary Dr. Mandy Cohen visited UNC Health’s main COVID-19 vaccination clinic at the Friday Center. In accordance with new federal recommendations, the state has given local entities the flexibility to begin vaccinating North Carolinians over the age of 65 and all […]

On Air Today: Dr. David Wohl on mRNA Vaccine Funding Cuts

Dr. David Wohl — an infectious disease researcher with UNC Health — speaks with 97.9 The Hill's Brighton McConnell on Wednesday, August 13.

Pfizer Vaccine to Soon Be Available for Children Ages 5-11; Duke Expert Weighs In

After months of clinical studies, federal regulators are poised to approve a COVID-19 vaccine for young children.

Duke, UNC Experts: COVID Vaccine for Ages 5-11 Expected by Late 2021

As the COVID-19 delta variant continues to spread across the country, and the academic year looms on the horizon, public health officials are working to vaccinate as much of the population as possible – including young children.

UNC, Duke Health To Require Staff COVID-19 Vaccinations by September

UNC Health, alongside other state healthcare systems, has announced that it will make COVID-19 vaccinations mandatory for all staff. According to a UNC Health statement, all staff must receive their vaccine by Tuesday, September 21. The message said the main goal of these mandatory COVID vaccinations is to “protect the health and safety of our […]

Heart Reaction Probed as Possible Rare Vaccine Link in Teens

Written by LINDSEY TANNER and LAURAN NEERGAARD Health authorities are trying to determine whether heart inflammation that can occur along with many types of infections could also be a rare side effect in teens and young adults after the second dose of COVID-19 vaccine. An article on seven U.S. teen boys in several states, published online […]

Moderna Says Its COVID-19 Shot Works in Kids as Young as 12

Written by LAURAN NEERGAARD Moderna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the U.S. With global vaccine supplies still tight, much of the world is struggling to vaccinate adults in the quest […]

›